NON-SMALL CELL CARCINOMA
Clinical trials for NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for tough lung cancer mutations
Disease control OngoingThis study compares a standard targeted therapy (osimertinib) alone versus the same drug plus chemotherapy for people with advanced non-small cell lung cancer that has both EGFR and TP53 gene mutations. About 294 participants will be randomly assigned to one of the two treatments…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: Li Zhang, MD • Aim: Disease control
Last updated May 26, 2026 07:53 UTC
-
Custom immune cells take on Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a personalized cell therapy called T-Plex for people with advanced solid tumors that have not responded to standard treatments. The therapy uses a patient's own immune cells, engineered to recognize and attack cancer cells. The main goal is to check s…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 07:25 UTC
-
New triple therapy hopes to shrink lung tumors after other treatments fail
Disease control OngoingThis study tests a combination of three drugs (zimberelimab, domvanalimab, and etrumadenant) in 30 adults with advanced non-small cell lung cancer who have already received immunotherapy. The goal is to see if the triple therapy can shrink tumors or stop them from growing. Partic…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
Blood test may spare thousands from unnecessary lung biopsies
Diagnosis OngoingThis study looks at whether a blood test called Nodify XL2 can help doctors better manage lung nodules that have a low to moderate chance of being cancer. About 2,000 adults over 40 with a solid lung nodule between 8 and 30 mm are taking part. The goal is to see if using the test…
Matched conditions: NON-SMALL CELL CARCINOMA
Sponsor: Biodesix, Inc. • Aim: Diagnosis
Last updated May 22, 2026 14:04 UTC